Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$48,487,541
in 9 filings, $47.8M under 10b5-1 plans

Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-09-10 AMGEN INC 10% owner Purchase +165,529 $302.06 $50.0M 18,943,802
2020-12-18 AMGEN INC 10% owner Grant or award +25,762 $260.95 $6.7M 18,778,273
2020-12-17 AMGEN INC 10% owner Grant or award +74,624 $260.54 $19.4M 18,752,511
2020-12-16 AMGEN INC 10% owner Grant or award +85,573 $248.26 $21.2M 18,677,887
2020-12-15 AMGEN INC 10% owner Grant or award +67,941 $239.31 $16.3M 18,592,314
2020-08-25 AMGEN INC 10% owner Grant or award +59,390 $248.49 $14.8M 18,524,373
2020-08-24 AMGEN INC 10% owner Grant or award +59,390 $239.10 $14.2M 18,464,983
2020-08-21 AMGEN INC 10% owner Grant or award +64,176 $230.18 $14.8M 18,405,593
2020-08-20 AMGEN INC 10% owner Grant or award +64,176 $234.99 $15.1M 18,341,417
2020-08-19 AMGEN INC 10% owner Grant or award +64,176 $234.88 $15.1M 18,277,241
2020-08-18 AMGEN INC 10% owner Grant or award +40,000 $230.18 $9.2M 18,213,065
2020-07-15 AMGEN INC 10% owner Grant or award +29,614,832 $14.23 $421.4M 236,249,845

Page 1 of 1 · 12 trades